Physician profile
Traci Kimbrough
NPI 1235242587
$9,426.73
in general payments reported to CMS, 2019-2025
38 companies · $1,946 in 2025
The $1,946 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,506 · 2020: $759 · 2021: $752 · 2022: $751 · 2023: $1,465 · 2024: $2,248 · 2025: $1,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,412 · Education: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,411.77 |
| Education | $246.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,675.01 | 2019-2025 | Tremfya |
| Pfizer INC. | $959.51 | 2019-2025 | |
| Abbvie INC. | $788.75 | 2019-2025 | |
| Genzyme Corporation | $750.71 | 2019-2025 | |
| Amgen INC. | $581.40 | 2019-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $491.47 | 2019-2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $486.31 | 2019-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $418.12 | 2019-2025 | Ilumya |
| Novartis Pharmaceuticals Corporation | $376.26 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $367.32 | 2019-2024 | Arazlo, Jublia, Cabtreo |
| Ucb, INC. | $358.62 | 2021-2025 | Bimzelx, Cimzia |
| Almirall LLC | $197.49 | 2019-2021 | |
| Incyte Corporation | $195.97 | 2023-2025 | Opzelura |
| Lilly USA, LLC | $191.33 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Biofrontera INC. | $169.67 | 2019-2023 | Ameluz, Xepi, Bf-Rhodoled |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci Kimbrough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.